The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non-Small Cell Lung Cancer | PTCE Pharmacy Connect

Pharmacy Podcast Network

Pharmacy Podcast Network द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Pharmacy Podcast Network या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

29d ago 35:32

MP3•एपिसोड होम

Educational Objectives

Review recent clinical updates of RET inhibitors and how they fit into the treatment paradigm for non‒small cell lung cancer
Identify and manage adverse effects of RET inhibitors to ensure patient safety and improve adherence

Faculty

Lauren Ledbetter, PharmD, BCOP

Clinical Pharmacy Specialist, Thoracic Medical Oncology

The James Cancer Hospital at The Ohio State University

Columbus, Ohio

Moderator

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager

University of Kansas Cancer Center

Division of Hematologic Malignancies & Cellular Therapeutics

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-24-304-H01-P. The activity is available for CE credit through October 31, 2025.

This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc.

1336 एपिसोडस

#News #Business News #Fitness #Medicine #Pharmacy Podcast Network #Podcasting Education #Annual Meeting